mr001
mAbexperimentalBi-specific
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2023 (NCT06134531)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
- Multi-specific
- Yes (Bi-specific)
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07235202 | Phase 1/Phase 2 (Phase 2) | Dec 22, 2025 | Government of China |
| NCT07208149 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2025 | Chinese Academy of Medical Sciences, Government of China |
| NCT06134531 | Phase 1 | Nov 30, 2023 | Southern Medical University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 1 | 2025 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
3 organizations
Page 1 / 1